Peer review reports
From: Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
Original Submission |
5 Mar 2021 |
Submitted |
Original manuscript
|
25 Mar 2021 |
Reviewed |
Reviewer Report
|
19 Apr 2021 |
Author responded |
Author comments - Marie D’hooghe
|
Resubmission - Version 2 |
19 Apr 2021 |
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
12 May 2021 |
Reviewed |
Reviewer Report
|
13 May 2021 |
Reviewed |
Reviewer Report
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
Publishing |
14 May 2021 |
Editorially accepted |
|
22 Jun 2021 |
Article published |
10.1186/s12883-021-02246-0
|
Learn about peer review